BRANFORD: THE WORLD’S ONLY HIV-DEDICATED RESEARCH CENTer
HIV is evolving, and so are we.
For people living with HIV (PLHIV), living a longer life can bring on new medical challenges. For instance, many PLHIV experience issues with co-morbidities, such as heart disease or diabetes, which require regular medication.1 That’s why we are continuing to advance the science of HIV to deliver new medicines that don’t interact with treatments for other conditions and have as few side effects as possible when taken over the long term.
The Branford research facility: the only HIV-dedicated research center
Collaboration is the key to finding the solutions to these challenges – and it’s at the heart of what we do at our HIV research facility in Branford, Connecticut, USA.
Opened in late 2017, the site hosts more than 30 specialist scientists working across the spectrum of medical development, from early-stage discovery through to development research. They are responsible for discovering and developing innovative treatments to help PLHIV.
Having these experts working together in the same laboratory facility enables us to be efficient and learn from each other in real time. This means that we can begin the clinical development process much earlier. Importantly, the learnings from clinical trials are immediately fed back to the discovery program, enabling development of future molecules.
Unlike other research sites, both the discovery and development phases of our clinical research are both in Branford. This means decisions can be made quickly, thanks to more efficient communications.
One of the strengths of our site here in Branford is that we sit side-by-side with early development. Anything that goes on in discovery they know about, anything that goes on in early development we know about, we collaborate in early development.
MARK KRYSTAL
Senior Director, Head of the Biology Group at ViiV Healthcare
